Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-14-039881)

Filing Details

Accession Number:: 0001144204-14-039881
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-26 18:02:31
Reporting Period:: 2014-06-23

Filing Date:: 2014-06-26
Accepted Time:: 2014-06-26 18:02:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
868278	Prophase Labs Inc.	PRPH	Pharmaceutical Preparations (2834)	232577138

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1457896	William Ted Karkus	621 N. Shady Retreat Road Doylestown PA 18901	Ceo & Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	Acquisiton	2013-06-23	58,370	$1.51	1,722,958	No	4	P	Direct
Common Stock, Par Value $0.0005	Acquisiton	2013-06-24	286,150	$1.56	2,009,108	No	4	P	Direct
Common Stock, Par Value $0.0005	Acquisiton	2013-06-25	155,480	$1.58	2,164,588	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.57, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.61, inclusive.